Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis

被引：0
|
作者：
Egeberg, A. [1 ]
Ottosen, M. B. [1 ]
Gniadecki, R. [2 ]
Broesby-Olsen, S. [3 ,4 ]
Dam, T. [5 ]
Bryld, L. E. [6 ]
Rasmussen, M. K. [7 ]
Skov, L. [1 ]
机构：
[1] Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark
[2] Bispebjerg Hosp, Dept Dermatol, Copenhagen, Denmark
[3] Odense Univ Hosp, Dept Dermatol, Odense, Denmark
[4] Odense Univ Hosp, Allergy Ctr, Odense, Denmark
[5] Skin Clin, Nykobing, Denmark
[6] Roskilde Hosp, Dept Dermatol, Roskilde, Denmark
[7] Aarhus Univ Hosp, Dept Dermatol, Aarhus, Denmark
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2017年 / 177卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P075
引用
收藏
页码：E284 / E285
页数：2
相关论文
共 50 条
  • [21] Treatment of moderate-to-severe plaque psoriasis
    Salgo, R.
    Thaci, D.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06): : 701 - 711
  • [22] Efficacy and safety of brodalumab in subpopulations of patients with difficult-to-treat moderate-to-severe plaque psoriasis
    Papp, Kim
    Menter, Alan
    Strober, Bruce
    Kricorian, Greg
    Thompson, ElizabethH. Z.
    Milmont, Cassandra E.
    Nirula, Ajay
    Klekotka, Paul
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (03) : 436 - U100
  • [23] Racial/ethnic differences in treatment efficacy and safety for moderate-to-severe plaque psoriasis: a systematic review
    Ferguson, Jessica E.
    Seger, Edward W.
    White, Jacob
    McMichael, Amy
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (01) : 41 - 50
  • [24] Safety and Efficacy of Brodalumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis
    Attia Attia
    Abdelrahman Ibrahim Abushouk
    Hussien Ahmed
    Mohamed Gadelkarim
    Ahmed Elgebaly
    Zeinab Hassan
    Mohamed M. Abdel-Daim
    Ahmed Negida
    Clinical Drug Investigation, 2017, 37 : 439 - 451
  • [25] Long-term efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis
    Zheng, Jianfeng
    Chen, Wenjuan
    Yi, Xuemei
    Yu, Ning
    Ding, Yangfeng
    Gao, Yunlu
    FRONTIERS IN MEDICINE, 2023, 10
  • [26] Racial/ethnic differences in treatment efficacy and safety for moderate-to-severe plaque psoriasis: a systematic review
    Jessica E. Ferguson
    Edward W. Seger
    Jacob White
    Amy McMichael
    Archives of Dermatological Research, 2023, 315 : 41 - 50
  • [27] Efficacy and safety of brodalumab versus ustekinumab in obese and nonobese patients with moderate-to-severe plaque psoriasis
    Yamauchi, Paul
    Elewski, Boni
    Wu, Jashin J.
    Rastogi, Shipra
    Israel, Robert J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB119 - AB119
  • [28] Safety and Efficacy of Brodalumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis
    Attia, Attia
    Abushouk, Abdelrahman Ibrahim
    Ahmed, Hussien
    Gadelkarim, Mohamed
    Elgebaly, Ahmed
    Hassan, Zeinab
    Abdel-Daim, Mohamed M.
    Negida, Ahmed
    CLINICAL DRUG INVESTIGATION, 2017, 37 (05) : 439 - 451
  • [29] Real-world data on the efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis
    Papadavid, E.
    Rompoti, N.
    Theodoropoulos, K.
    Kokkalis, G.
    Rigopoulos, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (07) : 1173 - 1179
  • [30] Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paper
    Yeung, Jensen
    Bourcier, Marc
    Gooderham, Melinda J.
    Grewal, Parbeer
    Hong, Chih-Ho
    Lansang, Perla
    Lynde, Charles
    Maari, Catherine
    Prajapati, Vimal H.
    Turchin, Irina
    Vender, Ron
    DERMATOLOGIC THERAPY, 2022, 35 (10)
12345